Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer. (Ronco-Onco)
Oral Cancer, Pharynx Cancer, Sleep Apnea
About this trial
This is an interventional supportive care trial for Oral Cancer focused on measuring oropharyngeal cancer, snoring, sleep apnea, oral appliance
Eligibility Criteria
Inclusion Criteria: oropharyngeal cancer diagnosis 18 years of age and over female or male; ratio of 1/4 toward men had received RTH in the Department of Radiation Oncology, reporting snoring and/or respiratory cessation complaints during sleep, Exclusion Criteria: pregnant or breastfeeding woman; edentation preventing retention of the oral appliance; taking opioid or anxiolitic type medications; history of major depression, uncontrolled hypertension, history of stroke; under treatment with CPAP for sleep apnea; regular and intense orofacial pain; under pharmacological treatment for insomnia; excessive alcohol or drug use (e.g., cannabis, opioid).
Sites / Locations
- CHUMRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
MAD-active
Neutral MAD- control
MAD = mandibular advancement appliance, in 60-70% forward position from maximum possible jaw advancement for a given participant
Mandibular advancement appliance in neurtral-control position, 10-20% of advancement - a non functional position to open upper airway